Infection. 2024 Oct 7. doi: 10.1007/s15010-024-02404-9. Online ahead of print.
ABSTRACT
Cefiderocol is a new siderophore-beta-lactam antibiotic used for the treatment of severe multidrug-resistant infections like sepsis, hospital-acquired and ventilator-associated pneumonia in adults, but there are only single reports on its use in the neonatal population. We describe the successful cefiderocol treatment of a newborn with pneumogenic sepsis due to Stenotrophomonas maltophilia.
PMID:39373949 | DOI:10.1007/s15010-024-02404-9
